γδ T cells provide an early source of interferon γ in tumor immunity

Journal of Experimental Medicine

Volumn 198, Issue 3, 2003, Pages 433-442

  Gao, Yunfei ^a   Yang, Wancai ^b   Pan, Meng ^a   Scully, Eileen ^a   Girardi, Michael ^a   Augenlicht, Leonard H ^b   Craft, Joe ^a   Yin, Zhinan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

Cytokines; Immune regulation; Immunosurveillance; Tumor immunosurveillance

Indexed keywords

3 METHYLCHOLANTHRENE; GAMMA INTERFERON; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CELL ACTIVATION; CHIMERA; CONTROLLED STUDY; FETUS LIVER; GENETIC DISORDER; IMMUNOSURVEILLANCE; INOCULATION; KNOCKOUT MOUSE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPECIES COMPARISON; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; TUMOR LOCALIZATION; WILD TYPE;

ANIMALS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION CHIMERA; TUMOR CELLS, CULTURED;

EID: 0042123726     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030584     Document Type: Article

References (38)

1. Ikeda, H., L.J. Old, and R.D. Schreiber. 2002. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 13:95-109.
2. Dunn, G.P., A.T. Bruce, H. Ikeda, L.J. Old, and R.D. Schreiber. 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3:991-998.
3. Kaplan, D.H., V. Shankaran, A.S. Dighe, E. Stockert, M. Aguet, L.J. Old, and R.D. Schreiber. 1998. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA. 95:7556-7561.
4. Street, S.E., E. Cretney, and M.J. Smyth. 2001. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood. 97:192-197.
5. Shankaran, V., H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, and R.D. Schreiber. 2001. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 410:1107-1111.
6. Dighe, A.S., E. Richards, L.J. Old, and R.D. Schreiber. 1994. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors. Immunity. 1:447-456.
7. Hayday, A.C. 2000. [gamma] [delta] cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 18:975-1026.
8. Lahn, M. 2000. The role of gammadelta T cells in the airways. J. Mol. Med. 78:409-425.
9. Carding, S.R., and P.J. Egan. 2000. The importance of gamma delta T cells in the resolution of pathogen-induced inflammatory immune responses. Immunol. Rev. 173:98-108.
10. Tough, D.F., and J. Sprent. 1998. Lifespan of gamma/delta T cells. J. Exp. Med. 187:357-365.
11. Kasper, L.H., T. Matsuura, S. Fonseka, J. Arruda, J.Y. Channon, and I.A. Khan. 1996. Induction of gammadelta T cells during acute murine infection with Toxoplasma gondii. J. Immunol. 157:5521-5527.
12. Tsuji, M., P. Mombaerts, L. Lefrancois, R.S. Nussenzweig, F. Zavala, and S. Tonegawa. 1994. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc. Natl. Acad. Sci. USA. 91:345-349.
13. Mombaerts, P., J. Arnoldi, F. Russ, S. Tonegawa, and S.H. Kaufmann. 1993. Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature. 365:53-56.
14. Moore, T.A., B.B. Moore, M.W. Newstead, and T.J. Standiford. 2000. Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumonia. J. Immunol. 165:2643-2650.
15. Huber, S.A., D. Graveline, M.K. Newell, W.K. Born, and R.L. O'Brien. 2000. V gamma 1 + T cells suppress and V gamma 4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J. Immunol. 165:4174-4181.
16. Nomura, A., G. Matsuzaki, H. Takada, K. Hiromatsu, S. Nabeshima, T. Nakamura, K. Kishihara, and K. Nomoto. 1998. The role of gammadelta T cells in induction of bacterial antigen-specific protective CD8+ cytotoxic T cells in immune response against the intracellular bacteria Listeria monocytogenes. Immunology. 95:226-233.
17. Moretto, M., B. Durell, J.D. Schwartzman, and I.A. Khan. 2001. Gamma delta T cell-deficient mice have a down-regulated CD8+ T cell immune response against Encephalitozoon cuniculi infection. J. Immunol. 166:7389-7397.
18. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K.H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA. 96:6879-6884.
19. Groh, V., A. Steinle, S. Bauer, and T. Spies. 1998. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science. 279:1737-1740.
20. Wu, J., Y. Song, A.B. Bakker, S. Bauer, T. Spies, L.L. Lanier, and J.H. Phillips. 1999. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:730-732.
21. Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:727-729.
22. Girardi, M., D.E. Oppenheim, C.R. Steele, J.M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R.E. Tigelaar, and A.C. Hayday. 2001. Regulation of cutaneous malignancy by gamma delta T Cells. Science. 294:605-609.
23. Aubagnac, S., M. Brahic, and J.F. Bureau. 2002. Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection. J. Virol. 76:5807-5812.
24. Kelly, K.A., R. O'Brien, and W. Born. 1997. Reconstitution of SCID mice with haemopoietic precursors: a detailed analysis of gamma delta T-cell reconstitution. Immunology. 91:65-72.
25. Yin, Z., D.H. Zhang, T. Welte, G. Bahtiyar, S. Jung, L. Liu, X.Y. Fu, A. Ray, and J. Craft. 2000. Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression. J. Immunol. 164:3056-3064.
26. Zhang, Y., L.L. McCormick, S.R. Desai, C. Wu, and A.C. Gilliam. 2002. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J. Immunol. 168:3088-3098.
27. Yin, Z., C. Chen, S.J. Szabo, L.H. Glimcher, A. Ray, and J. Craft. 2002. T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells. J. Immunol. 168:1566-1571.
28. Afkarian, M., J.R. Sedy, J. Yang, N.G. Jacobson, N. Cereb, S.Y. Yang, T.L. Murphy, and K.M. Murphy. 2002. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3:549-557.
29. O'Garra, A., and K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458-466.
30. Huber, S., C. Shi, and R.C. Budd. 2002. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J. Virol. 76:6487-6494.
31. Jouen-Beades, F., E. Paris, C. Dieulois, J.F. Lemeland, V. Barre-Dezelus, S. Marret, G. Humbert, J. Leroy, and F. Tron. 1997. In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans. Infect. Immun. 65:4267-4272.
32. Shires, J., E. Theodoridis, and A.C. Hayday. 2001. Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity. 15:419-434.
33. Fahrer, A.M., Y. Konigshofer, E.M. Kerr, G. Ghandour, D.H. Mack, M.M. Davis, and Y.H. Chien. 2001. Attributes of gammadelta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc. Natl. Acad. Sci. USA. 98:10261-10266.
34. Crowe, N.Y., M.J. Smyth, and D.I. Godfrey. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119-127.
35. Brutkiewicz, R.R., and V. Sriram. 2002. Natural killer T (NKT) cells and their role in antitumor immunity. Crit. Rev. Oncol. Hematol. 41:287-298.
36. Basse, P.H., T.L. Whiteside, W. Chambers, and R.B. Herberman. 2001. Therapeutic activity of NK cells against tumors. Int. Rev. Immunol. 20:439-501.
37. Roessner, K., J. Wolfe, C. Shi, L.H. Sigal, S. Huber, and R.C. Budd. 2003. High expression of Fas ligand by synovial fluid-derived gamma delta T cells in Lyme arthritis. J. Immunol. 170:2702-2710.
38. + lymphocytes recognize tumor cells of epithelial origin. J. Exp. Med. 183:1681-1696.